|
End-of-day quote
Nasdaq
|
||
| - USD | - |
|
| 14/08 | CASI Pharmaceuticals, Inc. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 14/08 | Casi Pharmaceuticals, Inc. Announces Management Changes | CI |
| Market Cap | 31.45L 27.06L 25.46L 23.26L 43.51L 30Cr 43.63L 3.01Cr 1.17Cr 15Cr 1.18Cr 1.16Cr 49Cr | P/E 2024 |
-1.11x | P/E 2025 | -0.33x |
|---|---|---|---|---|---|
| Enterprise Value | 2.5Cr 2.15Cr 2.02Cr 1.85Cr 3.46Cr 236.03Cr 3.47Cr 24Cr 9.28Cr 121.1Cr 9.39Cr 9.18Cr 390.13Cr | EV / Sales 2024 |
1.75x | EV / Sales 2025 | 1.9x |
| Free-Float |
53.62% | Yield 2024 * |
-
| Yield 2025 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
David Cory
CEO | Chief Executive Officer | 62 | 21/07/2025 |
Kun Qian
DFI | Director of Finance/CFO | 44 | 16/05/2025 |
Chun Hua Wang
COO | Chief Operating Officer | 54 | 01/01/2017 |
| Director | Title | Age | Since |
|---|---|---|---|
Yue Wu
BRD | Director/Board Member | 62 | 01/04/2013 |
Zhen Bo Su
BRD | Director/Board Member | 50 | 21/03/2023 |
Thomas Folinsbee
BRD | Director/Board Member | 59 | 21/03/2023 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.64% | -2.88% | +53.56% | +104.38% | 1,03400Cr | |
| -1.02% | +2.81% | +54.16% | +71.50% | 67TCr | |
| -1.46% | +0.27% | +20.26% | +75.33% | 46TCr | |
| +0.14% | -0.47% | +29.49% | +38.56% | 35TCr | |
| -1.33% | +4.72% | +24.69% | +45.55% | 31TCr | |
| -1.15% | +0.30% | -1.49% | +12.31% | 26TCr | |
| -1.63% | +1.02% | +55.96% | +71.98% | 24TCr | |
| -0.88% | +1.15% | -17.09% | -54.39% | 21TCr | |
| -0.53% | +3.36% | +33.52% | +100.33% | 19TCr | |
| Average | -1.02% | +1.27% | +28.12% | +51.73% | 41.3TCr | |
| Weighted average by Cap. | -1.15% | +1.04% | +36.28% | +66.23% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 2.85Cr 2.46Cr 2.31Cr 2.11Cr 3.95Cr 269.43Cr 3.96Cr 27Cr 11Cr 138.24Cr 11Cr 10Cr 445.34Cr | 2.07Cr 1.78Cr 1.68Cr 1.53Cr 2.87Cr 195.55Cr 2.87Cr 20Cr 7.69Cr 100.33Cr 7.78Cr 7.61Cr 323.23Cr |
| Net income | -3.93Cr -3.38Cr -3.18Cr -2.9Cr -5.43Cr -370.66Cr -5.45Cr -38Cr -15Cr -190.17Cr -15Cr -14Cr -612.65Cr | -4.81Cr -4.14Cr -3.89Cr -3.55Cr -6.65Cr -453.74Cr -6.67Cr -46Cr -18Cr -232.8Cr -18Cr -18Cr -749.98Cr |
| Net Debt | 60.5L 52.06L 48.98L 44.74L 83.7L 57Cr 83.93L 5.79Cr 2.25Cr 29Cr 2.27Cr 2.22Cr 94Cr | 2.19Cr 1.88Cr 1.77Cr 1.62Cr 3.02Cr 206.34Cr 3.03Cr 21Cr 8.11Cr 105.86Cr 8.21Cr 8.03Cr 341.05Cr |
Employees
-
Sector
Pharmaceuticals
Select your edition
All financial news and data tailored to specific country editions
